Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0YRWKE
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-GPC3 mAb 4A6-IIIc-04
|
|||||
| Synonyms |
Anti-GPC3-mAb-4A6-IIIc-04
Click to Show/Hide
|
|||||
| Organization |
Bristol Myers Squibb Co.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Hepatocellular carcinoma [ICD11:2C12]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2.5-3.0
|
|||||
| Antibody Name |
Anti-GPC3 mAb 4A6
|
Antibody Info | ||||
| Antigen Name |
Glypican-3 (GPC3)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Anti-GPC3 mAb 4A6-IIIc-04 linker
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.